Financials

All figs in ₹ Crores

(Please use a modern browser to see the interactive version of this visualization)

Bio Pharma Undertaking also contains bio-polymers business which is shown under remaining business. For FY 2024, the revenue of the same was circa INR 45 crore. Unallocable assets & liabilities for FY 2024 was INR 560 crore & INR 1732 crore respectively on which no clarity has been given.

Chart: www.mnacritique.mergresindia.comSource: Company's Annual ReportsCreated with Datawrapper